Utah legislation · 2025 General Session
Utah HB519: Health Care Access Amendments
Status: Failed, March 7, 2025
This bill addresses the 340B drug discount program.
What the bill says
From the introduced text:
Health Care Access Amendments 2025 GENERAL SESSION STATE OF UTAH Chief Sponsor: Steve Eliason Senate Sponsor: Evan J. Vickers LONG TITLE General Description: This bill addresses the 340B drug discount program. Highlighted Provisions: This bill: - defines a term; - prohibits a pharmaceutical manufacturer from restricting, prohibiting, or otherwise interfering with a 340B entity's ability to: - acquire a 340B drug; or - participate in the 340B drug discount program; and - permits the Public Employees' Benefit and Insurance Program to adjust its business practices to mitigate any resulting financial impacts. Money Appropriated in this Bill: None Other Special Clauses: None Utah Code Sections Affected: ENACTS: 31A-46-311 , Utah Code Annotated 1953 Be it enacted by the Legislature of the state of Utah: Section 1, Section 31A-46-311 is enacted to read: 31A-46-311. Prohibited actions with respect to the 340B drug discount program. (1) As used in this section,"manufacturer" means a pharmaceutical manufacturer, including an agent or affiliate of a pharmaceutical manufacturer. (2) A manufacturer may not: (a) directly or indirectly restrict or prohibit: (i) a pharmacy from contracting with a 340B entity, including by denying the pharmacy access to a drug that is manufactured by the manufacturer; (ii) a 340B entity from contracting with a pharmacy, including by denying the 340B entity access to a drug that is manufactured by …
Sponsors
- Steve Eliason (R, 43) · primary sponsor
- Evan Vickers (R, 28)
- Cheryl Acton (R, 38)
- Carl Albrecht (R, 70)
- Tiara Auxier (R, 4)
- Ballard, Melissa G. (R, 20)
- Barlow, Stewart E. (R, 17)
- Bennion, Gay (D)
- Bolinder, Bridger (R, 29)
- Brooks, Walt (R, 75)
- Chevrier, Kristen (R, 54)
- Tyler Clancy (R, 60)
Latest actions
- : Senate/ 2nd Reading Calendar to Rules
- : House/ filed
- : House/ received from Senate
- : Senate/ to House
- : Senate/ strike enacting clause
- : Senate/ circled
- : Senate/ 2nd reading
- : LFA/ fiscal note publicly available for HB0501S04
- : LFA/ fiscal note sent to sponsor for HB0501S04
- : LFA/ bill sent to agencies for fiscal input for HB0501S04
Votes
- House/ passed 3rd reading (March 4, 2025): 73 yea, 0 nay, passed
- House/ passed 3rd reading (February 28, 2025): 69 yea, 0 nay, passed
- House Comm - Favorable Recommendation (February 25, 2025): 12 yea, 0 nay, passed
Subjects: Health Care, Health Insurance, Health and Human Services, Public Employees' Health Program, Public Retirement and Insurance, Pharmaceuticals, Public Employees Insurance and Benefits
Common questions
- What is HB519?
- HB519 is a bill in the Utah Legislature (2025 General Session): Health Care Access Amendments.
- What does HB519 do?
- This bill addresses the 340B drug discount program.
- What is the status of HB519?
- Failed as of March 7, 2025. Latest action: Senate/ 2nd Reading Calendar to Rules (March 7, 2026).
- Who sponsored HB519?
- Steve Eliason (R, 43), with 11 co-sponsors.
- Where is the official record for HB519?
- On the Utah Legislature website: https://le.utah.gov/~2025/bills/static/HB0519.html
Source: official Utah record. Tracked by Delilah, AI for legislation across all 50 states and Congress.